missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human mDIC (aa 75-145) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (80%), Rat (80%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The mitochondrial dicarboxylate carrier protein (mDIC) belongs to superfamily of mitochondrial transporters. It has been demonstrated that the expression of mDIC leads to hyperpolarization of the mitochondria, as well as succinate uptake by the mitochondria. It is highly expressed in adipose tissue, where its expression is downregulated by insulin and upregulated by free fatty acids. mDIC is also thought to play a role in glyceroneogenesis.
Specifications
Specifications
| Accession Number | Q9UBX3 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 1468 |
| Name | Human mDIC (aa 75-145) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | DIC; dicarboxylate ion carrier; dicarboxylate transporter), member 10; mitochondrial dicarboxylate carrier; Slc25a10; solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 10; solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10; solute carrier family 25 member 10 |
| Common Name | mDIC |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction